Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: VAUGHN who wrote (8548)	1/28/2002 3:41:46 PM
From: Cal Gary	Respond to of 14101

Thanks Vaughn for posting. Much appreciated. I've read this two times, trying to get to the essence of the conclusion. I'll have to visit the web site to check out what hard evidence there is to support their conclusion. It's hard not to take out the emotions, the political worldview I hold and try to objectively understand the conclusion. The conclusions seems so Canadian! Several possible ways to look at the conclusion, it depends on your emotion view, or polical stripe, or level headed view: 1. According to Kelly, the blame falls on the Federal Government. I got to see the evidence for this. 2. Return a mere $70mm back to the HC budget, the backlog goes away, citizens get access to new drugs, saves money at the other end by keeping people out of the hospital beds, emergency rooms. 3. I can understand the TPD's need for more staff and facilities, but more 'financial resources'?? For what? Are they into banking or pension? 4. Protection Money. Hand over the money and the problem will go away. 5. Will putting back $ into the budget end up hiring more TCP staff or would the $ go into the administration or beauracacy? See Ralph Klien. 6. Lots of questions. What does $70mm canadian tax payer dollars buy? Will there be a watch dog to make sure the $ goes where its intended and that the backlog will go away? Who will be accountable if it doesn't happen? With respect to DMX and: "the arm of Health Canada responsible for drug review and post-market surveillance, told delegates at The Canadians for Best Medicines Summit there is a delay of 18 months or more before anyone at Health Canada even looks at new drug submissions. However, once the submission gets out of the massive in-box and into the hands of a reviewer, Canada's review process is comparable to the U.S. and Europe. " Well TPD admits 18 months delay. Are we in the first case or the second? My thoughts are we are in the latter. Hard fact, HC late by almost 5 months to respond to the second Phase III resubmission. So its not happening in DMX's submission. How long do DMX wait before handing out the Pink slips for the Canadian sales force. If the second P3 submission sits in the first case, why did DMX ever ramp up the Canadian sales? I can only see Pink in this case and fast. I was expecting a more sophisticated solution/conclusion.